4//SEC Filing
KIRKMAN ROBERT L 4
Accession 0001130166-05-000023
CIK 0001130166other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 8:59 PM ET
Size
6.1 KB
Accession
0001130166-05-000023
Insider Transaction Report
Form 4
KIRKMAN ROBERT L
Chief Business Officer and VP
Transactions
- Award
Employee Stock Option (Right to Buy)
2005-02-03$2.29/sh+40,000$91,600→ 40,000 totalExercise: $2.29Exp: 2015-02-03→ Common (40,000 underlying)
Footnotes (2)
- [F1]Option grant is granted under the Company's 2003 Stock Plan which was amended by the Board of Directors on January 28, 2005 but is still subject to stockholders' approval at the Company's next annual stockholders' meeting.
- [F2]On February 3, 2005, this reporting person was granted an Option to purchase shares of Common Stock. This Option vests and becomes exercisable based on the satisfaction of certain company milestones as determined by the Board of Directors of Xcyte Therapies, except that in any event, 100% of the unvested Option shall vest upon the date that is the four-year anniversary of the vesting commencement date of such Option.
Documents
Issuer
XCYTE THERAPIES INC
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001242122
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 8:59 PM ET
- Size
- 6.1 KB